EP2935303
4´-flúor-núkleósíð, 4´-flúor-núkleótíð og afleiður þeirra til meðhöndlunar á HCV
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
19.12.2013EP published:
17.2.2021EP application number:
13864403.4
EP translation filed:
8.4.2021Grant published:
15.5.2021EPO information:
European Patent Register
Max expiry date:
18.12.2033Expiry date:
18.12.2026Next due date:
31.12.2026
Title:
4'-FLUORO-NUCLEOSIDES, 4'-FLUORO-NUCLEOTIDES AND ANALOGS THEREOF FOR THE TREATMENT OF HCV
Timeline
Today
19.12.2013EP application
17.2.2021EP Publication
8.4.2021Translation submitted
15.5.2021Registration published
18.12.2026Expires
Owner
Name:
Janssen BioPharma, Inc.Address:
260 E. Grand Avenue, 2nd Floor, South San Francisco, CA 94080, US
Inventor
Name:
BEIGELMAN, LeonidAddress:
San Mateo, CA 94402, US
Name:
WANG, GuangyiAddress:
Carlsbad, CA 92008, US
Name:
SMITH, David, BernardAddress:
San Mateo, CA 94403, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201261745466 PDate:
21.12.2012Country:
US
Number:
201361890125 PDate:
11.10.2013Country:
US
Classification
Categories:
C07H 19/067, C07H 19/073, C07H 19/10, C07H 19/167, C07H 19/173, C07H 19/20, C07H 19/213, A61K 31/708, A61K 31/7076, A61K 31/7072, A61K 31/7068, A61P 31/14
Annual fees
Number
Paid
Expires
Payer
Number: 9
Paid: 8.11.2021
Expires: 18.12.2022
Payer: Árnason Faktor ehf.
Number: 10
Paid: 9.11.2022
Expires: 18.12.2023
Payer: Árnason Faktor ehf.
Number: 11
Paid: 11.12.2023
Expires: 18.12.2024
Payer: Árnason Faktor ehf.
Number: 12
Paid: 5.11.2024
Expires: 18.12.2025
Payer: Árnason Faktor ehf.
Number: 13
Paid: 15.12.2025
Expires: 18.12.2026
Payer: Árnason Faktor ehf.